Week39, 2024
1. Influenza activity remains low nationwide, with 0.5% of respiratory specimens testing positive for influenza in clinical labs.
2. Of these positive specimens, 78% were Influenza A and 22% were Influenza B.
3. Public health labs found 95.6% of positive specimens to be Influenza A, with 72.2% subtyped as H1N1 and 27.8% as H3N2, while 4.4% were Influenza B, all of Victoria lineage.
4. Two human cases of Influenza A(H5) were reported in California, linked to the HPAI A(H5N1) outbreak in dairy cows; 16 such cases have been reported this season.
5. Weekly hospitalization rates remained stable at 0.1 per 100,000 population, with a cumulative total of 25,456 hospitalizations since October 2023.
6. Influenza A caused 84.6% of hospitalizations, predominantly H1N1 (67.5%), while Influenza B accounted for 14.8%, with no Yamagata lineage detected.
7. Outpatient visits for respiratory illness remained stable nationally and are below the baseline, with variations in regional activity influenced by co-circulating viruses.
8. Vaccination is urged for everyone aged 6 months and older, but vaccination trends were not discussed in this report.
9. The percentage of deaths attributed to influenza and pneumonia has remained stable and is below epidemic levels.
10. Co-circulation of other respiratory viruses, including COVID-19 and RSV, impacts ILI and healthcare-seeking patterns, necessitating integrated surveillance data for accurate predictions of activity trends.